Clinical Trials
16 trialsNCT05201859 2026-05-07
Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Active not recruiting
NCT07303283 2026-03-05
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
Guangxi Medical University
Phase 2 Not yet recruiting
NCT05126719 2026-02-06
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma
Shanghai Miracogen Inc.
Phase 2 Active not recruiting
NCT07331428 2026-01-09
MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06987123 2025-05-23
TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT04517214 2025-04-02
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
Fudan University
Phase 2 Active not recruiting
NCT06331845 2024-03-26
Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06259721 2024-03-07
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital
Phase 2 Recruiting
NCT04072107 2023-06-18
EP-STAR
Sun Yat-sen University
Phase 2 Unknown
NCT05549466 2023-02-08
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
Sun Yat-sen University
Phase 2 Unknown
NCT05514275 2022-08-24
Radiotherapy Combined With Endostatin and Capecitabine for NPC
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT05484375 2022-08-02
Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Not yet recruiting
NCT05290194 2022-04-14
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Recruiting
NCT04220528 2020-01-07
Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC
Fujian Cancer Hospital
Phase 2 Unknown
NCT03427359 2018-02-09
Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
The University of Hong Kong-Shenzhen Hospital
Phase 2 Completed
NCT02360501 2016-04-20
Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Completed